Lataa...
RANKL-Targeted Therapies: The Next Frontier in the Treatment of Male Osteoporosis
Male osteoporosis is an increasingly recognized problem in aging men. A common cause of male osteoporosis is hypogonadism. Thousands of men with prostate cancer are treated with androgen deprivation therapy, a treatment that dramatically reduces serum testosterone and causes severe hypogonadism. Men...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
SAGE-Hindawi Access to Research
2011
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3196262/ https://ncbi.nlm.nih.gov/pubmed/22013547 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4061/2011/941310 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|